AstraZeneca Expands Prescription Savings Program
July 23 2009 - 7:00AM
PR Newswire (US)
WILMINGTON, Del., July 23 /PRNewswire-FirstCall/ -- AstraZeneca
(NYSE: AZN) announced today it is expanding its prescription
savings program by immediately extending assistance to qualifying
patients who have recently lost their jobs, had their incomes
reduced, or experienced a change in marital status or family size.
Previously, patients who experienced a change in income or family
size had difficulty applying to the program if their W2 statements
showed a non-qualifying income. Now, qualifying people who provide
documentation of their current income and family size can enroll
more easily and receive their AstraZeneca medicines more quickly.
"AstraZeneca is committed to helping patients get the medicines
they need," said Rich Fante, US President, AstraZeneca
Pharmaceuticals LP. "Our responsibility goes beyond developing
medicines to also making them available to those who cannot afford
them." For more than 30 years, AstraZeneca has offered patient
assistance programs side-by-side with its medicines. In 2008,
AstraZeneca helped more than 440,000 people fill 2.7 million
prescriptions resulting in $612 million of savings to patients.
AstraZeneca provides free or low-cost medicines to patients through
its AZ&Me(TM) Prescription Savings programs in three ways: --
AZ&Me(TM) Prescription Savings program for people without
insurance: AstraZeneca provides AstraZeneca medicines at no cost to
qualifying individuals without prescription drug coverage who make
up to $30,000 per year and families of four who make up to $60,000
per year. -- AZ&Me(TM) Prescription Savings program for people
with Medicare Part D: AstraZeneca provides low-cost AstraZeneca
medicines for qualifying Medicare Part D patients who make up to
$30,000 per year or couples who make up to $40,000 per year. --
AZ&Me(TM) Prescription Savings program for healthcare
facilities: AstraZeneca provides AstraZeneca medicines at no cost
to qualifying non-profit healthcare facilities, such as
disproportionate share hospitals, community health centers and
community free clinics. This program connects patients to the
AstraZeneca medicines they need at the same time and place they
receive their treatment. Patients can learn more about the
AZ&Me(TM) Prescription Savings program at
http://www.azandme.com/ or by calling 1-800-AZandMe. About
AstraZeneca AstraZeneca is engaged in the research, development,
manufacturing and marketing of meaningful prescription medicines
and in the supply of healthcare services. AstraZeneca is one of the
world's leading pharmaceutical companies with global healthcare
sales of $31.6 billion and is a leader in gastrointestinal,
cardiovascular, neuroscience, respiratory, oncology and infectious
disease medicines. In the United States, AstraZeneca is a $13.5
billion dollar healthcare business. For more information about
AstraZeneca in the US or our AZ&Me(TM) Prescription Savings
programs, please visit: http://www.astrazeneca-us.com/. DATASOURCE:
AstraZeneca CONTACT: Tony Jewell of AstraZeneca, +1-302-885-4594
Web Site: http://www.astrazeneca-us.com/
Copyright